NFSG
CUE icon

Newbridge Financial Services Group’s Cue Biopharma CUE Stock Holding History

Newbridge Financial Services Group’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.12K Sell
99
-1
-1% -$23 ﹤0.01% 1029
2026
Q1 		$690 Hold
100
– – ﹤0.01% 1098
2025
Q4 		$916 Hold
100
– – ﹤0.01% 1085
2025
Q3 		$2.16K Hold
100
– – ﹤0.01% 1126
2025
Q2 		$2.05K Sell
100
-17
-15% -$363 ﹤0.01% 1136
2025
Q1 		$3.19K Buy
117
+17
+17% +$631 ﹤0.01% 845
2024
Q4 		$3.27K Hold
100
– – ﹤0.01% 913
2024
Q3 		$2.27K Hold
100
– – ﹤0.01% 558
2024
Q2 		$3.72K Hold
100
– – ﹤0.01% 888
2024
Q1 		$5.67K Hold
100
– – ﹤0.01% 868
2023
Q4 		$7.92K Sell
100
-33
-25% -$2.36K ﹤0.01% 789
2023
Q3 		$9.2K Sell
133
-34
-20% -$3.32K ﹤0.01% 836
2023
Q2 		$18.3K Hold
167
– – 0.01% 722
2023
Q1 		$17.9K Sell
167
-400
-71% -$38.1K 0.01% 766
2022
Q4 		$48.5K Hold
567
– – 0.03% 472
2022
Q3 		$38K Buy
567
+167
+42% +$14.4K 0.02% 518
2022
Q2 		$30K Buy
400
+267
+201% +$31.2K 0.02% 534
2022
Q1 		$20K Hold
133
– – 0.01% 730
2021
Q4 		$45K Hold
133
– – 0.02% 489
2021
Q3 		$58K Hold
133
– – 0.04% 373
2021
Q2 		$47K Hold
133
– – 0.03% 456
2021
Q1 		$49K Hold
133
– – 0.04% 403
2020
Q4 		$50K Hold
133
– – 0.04% 334
2020
Q3 		$60K Buy
+133
New +$76.6K 0.06% 283

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Newbridge Financial Services Group's CUE Position: Q2 2026 in Review

Newbridge Financial Services Group reduced its Cue Biopharma (CUE) stake by 1% in Q2 2026, selling an estimated $23 and leaving 99 shares worth $3.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1029.

Newbridge Financial Services Group first reported a position in CUE in Q3 2020 and has held it in 24 quarters since. The position peaked at $60K in Q3 2020. 49 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Newbridge Financial Services Group held 99 shares of Cue Biopharma worth $3.12K as of Q2 2026.
  • Newbridge Financial Services Group sold 1 Cue Biopharma share in Q2 2026, an estimated $23.
  • Cue Biopharma made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #1029 holding.
  • Newbridge Financial Services Group first reported a position in Cue Biopharma in Q3 2020 and has held it in 24 quarters since.
  • Newbridge Financial Services Group's Cue Biopharma position peaked at $60K in Q3 2020.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.